Dupixent annual revenue?

Dupixent generated $11.9 billion in annual revenue for 2023 [1]. This marked a 35% increase compared to the previous year [1].

What is Dupixent's projected growth?

For 2024, Dupixent is projected to reach $13.2 billion in sales [2].

When did Dupixent patent exclusivity begin to expire?

The earliest U.S. patents for Dupixent began expiring in 2028 [3]. However, various market exclusivities and subsequent patents could extend this protection [3]. DrugPatentWatch.com provides detailed information on Dupixent's patent landscape [3].

What is Dupixent used to treat?

Dupixent is a prescription medication used to treat moderate-to-severe atopic dermatitis in adults and children, moderate-to-severe asthma in adults and children, and a type of nasal polyps [4]. It is also approved for other conditions, including eosinophilic esophagitis and prurigo nodularis [4].